Stock 9939 KINTOR PHARMACEUTICAL LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Kintor Pharmaceutical Limited

Equities

9939

KYG5273B1077

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:20 2024-04-26 EDT 		5-day change 1st Jan Change
0.96 HKD +2.13% Intraday chart for Kintor Pharmaceutical Limited +10.34% -41.10%
04-22 Kintor Pharmaceutical Limited Announces Phase II Clinical Trial of GT20029 for Treatment of Androgenetic Alopecia in China Reaches Primary Endpoint CI
04-22 Kintor Pharmaceutical Concludes Phase II Clinical Trial for Androgenic Alopecia Treatment MT

Evolution of the average Target Price on Kintor Pharmaceutical Limited

Price target over the last 5 years

History of analyst recommendation changes

bbb5a4dbe562676bdc368987ec.-XcIbSOTBJy7gyHwbf9qWKqFz75Q-zCnfg67H6gOxvA.r0NdWxvmMaWL5lKaVZcHa8nhpewbgnzKB0ziUeNF95fLB38VbN1K0MnxQg~c4da0ce3626de1246a111b6ea9910400

Analyst Recommendations on Kintor Pharmaceutical Limited

Kintor Proxalutamide's Covid-19 Clinical Trial Shows Significant Reduction in Hospitalization and Ventilation Rates CI
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.8886 CNY
Average target price
13.21 CNY
Spread / Average Target
+1,386.53%
High Price Target
13.21 CNY
Spread / Highest target
+1,386.53%
Low Price Target
13.21 CNY
Spread / Lowest Target
+1,386.53%

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 9939 Stock
  4. Consensus Kintor Pharmaceutical Limited